In patients with esophageal cancer and metabolic syndrome, an expedited surgical protocol was associated with greater reductions in circulating chemerin levels than the standard protocol, alongside decreases in inflammatory markers such as TNF-α, high-sensitivity CRP, and leptin; these changes coincided with improved lipid metabolism, nutritional recovery, and quality-of-life scores [34]. The gene discussed is RARRES2; the disease is metabolic syndrome.